Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

The long-term financial consequences of breast cancer: a Danish registry-based cohort study.

Jensen LS, Overgaard C, Bøggild H, Garne JP, Lund T, Overvad K, Fonager K.

BMC Public Health. 2017 Oct 30;17(1):853. doi: 10.1186/s12889-017-4839-x.

2.

The impact of prior psychiatric medical treatment on return to work after a diagnosis of breast cancer: A registry based study.

Jensen LS, Overgaard C, Garne JP, Bøggild H, Fonager K.

Scand J Public Health. 2017 Aug 1:1403494817722291. doi: 10.1177/1403494817722291. [Epub ahead of print]

PMID:
28789594
3.

Can registry data be used as a proxy for perceived stress? A cross-sectional study.

Jensen LS, Overgaard C, Garne JP, Carlsen K, Bøggild H, Fonager K.

Ann Epidemiol. 2016 Jul;26(7):493-499. doi: 10.1016/j.annepidem.2016.05.008. Epub 2016 May 31.

PMID:
27365259
4.

Prevalence and predictors of distress in women taking part in surgical continuity of care for breast cancer: A cohort study.

Jørgensen L, Laursen BS, Garne JP, Sherman KA, Søgaard M.

Eur J Oncol Nurs. 2016 Jun;22:30-6. doi: 10.1016/j.ejon.2016.01.004. Epub 2016 Mar 14.

PMID:
27179890
5.

Risk of non-sentinel node metastases in patients with symptomatic cancers compared to screen-detected breast cancers.

Tvedskov TF, Jensen MB, Balslev E, Garne JP, Vejborg I, Christiansen P, Ejlertsen B, Kroman N.

Acta Oncol. 2016;55(4):455-9. doi: 10.3109/0284186X.2015.1094186. Epub 2015 Oct 9.

PMID:
26452696
6.

The experience of distress in relation to surgical treatment and care for breast cancer: An interview study.

Jørgensen L, Garne JP, Søgaard M, Laursen BS.

Eur J Oncol Nurs. 2015 Dec;19(6):612-8. doi: 10.1016/j.ejon.2015.03.009. Epub 2015 May 8.

PMID:
25963860
7.

Age at diagnosis in relation to survival following breast cancer: a cohort study.

Brandt J, Garne JP, Tengrup I, Manjer J.

World J Surg Oncol. 2015 Feb 7;13:33. doi: 10.1186/s12957-014-0429-x.

8.

Relative mortality rates from incident chronic diseases among breast cancer survivors--a 14 year follow-up of five-year survivors diagnosed in Denmark between 1994 and 2007.

Ording AG, Boffetta P, Garne JP, Nyström PM, Cronin-Fenton D, Frøslev T, Silliman R, Sørensen HT, Lash TL.

Eur J Cancer. 2015 Apr;51(6):767-75. doi: 10.1016/j.ejca.2015.02.001. Epub 2015 Mar 9.

PMID:
25765753
9.

Sentinel Lymph Node Dissection in Locally Recurrent Breast Cancer.

Uth CC, Christensen MH, Oldenbourg MH, Kjær C, Garne JP, Teilum D, Kroman N, Tvedskov TF.

Ann Surg Oncol. 2015 Aug;22(8):2526-31. doi: 10.1245/s10434-014-4338-6. Epub 2015 Jan 7.

PMID:
25564177
10.

Development of a questionnaire encompassing indicators of distress: a tool for use with women in surgical continuity of care for breast cancer.

Jørgensen L, Garne JP, Søgaard M, Laursen BS.

Eur J Oncol Nurs. 2015 Apr;19(2):129-35. doi: 10.1016/j.ejon.2014.10.007. Epub 2014 Nov 18.

PMID:
25465772
11.

Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a Danish population-based cohort study.

Ording AG, Horváth-Puhó E, Garne JP, Nyström PW, Vyberg M, Sørensen HT, Lash TL.

BMJ Open. 2014 Jun 5;4(6):e005082. doi: 10.1136/bmjopen-2014-005082.

12.

Comments to the paper: Influence of mammography screening on use of mastectomies in Denmark.

Christiansen P, Vejborg I, Kroman N, Holten I, Garne JP, Vedsted P, Møller S, Lynge E.

Acta Oncol. 2015 Jan;54(1):135-6. doi: 10.3109/0284186X.2014.920961. Epub 2014 Jun 1. No abstract available.

PMID:
24881501
13.

Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysis.

Cronin-Fenton DP, Christensen M, Lash TL, Ahern TP, Pedersen L, Garne JP, Ewertz M, Autrup H, Sørensen HT, Hamilton-Dutoit S.

PLoS One. 2014 Jan 31;9(1):e87450. doi: 10.1371/journal.pone.0087450. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e92620.

14.

Position paper: breast cancer screening, diagnosis, and treatment in Denmark.

Christiansen P, Vejborg I, Kroman N, Holten I, Garne JP, Vedsted P, Møller S, Lynge E.

Acta Oncol. 2014 Apr;53(4):433-44. doi: 10.3109/0284186X.2013.874573. Epub 2014 Feb 5. Review.

PMID:
24495043
15.

Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis--a Danish nationwide matched cohort study.

Ording AG, Garne JP, Nyström PM, Frøslev T, Sørensen HT, Lash TL.

PLoS One. 2013 Oct 9;8(10):e76013. doi: 10.1371/journal.pone.0076013. eCollection 2013.

16.

Over-diagnosis estimate from The Independent UK Panel on Breast Cancer Screening is based on unsuitable data.

Njor SH, Garne JP, Lynge E.

J Med Screen. 2013 Jun;20(2):104-5. doi: 10.1177/0969141313495190. No abstract available.

PMID:
24065032
17.

Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.

Sørensen GV, Ganz PA, Cole SW, Pedersen LA, Sørensen HT, Cronin-Fenton DP, Garne JP, Christiansen PM, Lash TL, Ahern TP.

J Clin Oncol. 2013 Jun 20;31(18):2265-72. doi: 10.1200/JCO.2012.43.9190. Epub 2013 May 6.

18.

Existing data sources for clinical epidemiology: the Danish Quality Database of Mammography Screening.

Langagergaard V, Garne JP, Vejborg I, Schwartz W, Bak M, Lernevall A, Mogensen NB, Larsson H, Andersen B, Mikkelsen EM.

Clin Epidemiol. 2013;5:81-8. doi: 10.2147/CLEP.S40484. Epub 2013 Mar 14.

19.

Hospital recorded morbidity and breast cancer incidence: a nationwide population-based case-control study.

Ording AG, Garne JP, Nyström PM, Cronin-Fenton D, Tarp M, Sørensen HT, Lash TL.

PLoS One. 2012;7(10):e47329. doi: 10.1371/journal.pone.0047329. Epub 2012 Oct 19.

20.

[Danish Quality Database for Mammography Screening].

Vejborg I, Mikkelsen EM, Schwartz W, Bak M, Lernevall A, Borg Mogensen N, Garne JP.

Ugeskr Laeger. 2012 Oct 15;174(42):2533. Danish. No abstract available.

PMID:
23079436
21.

Completeness of breast cancer staging in the Danish Cancer Registry, 2004-2009.

Ording AG, Nielsson MS, Frøslev T, Friis S, Garne JP, Søgaard M.

Clin Epidemiol. 2012;4 Suppl 2:11-6. doi: 10.2147/CLEP.S31574. Epub 2012 Aug 17.

22.

Predictors of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study.

Winther Lietzen L, Cronin-Fenton D, Garne JP, Kroman N, Silliman R, Lash TL.

Eur J Surg Oncol. 2012 May;38(5):407-12. doi: 10.1016/j.ejso.2012.02.184. Epub 2012 Mar 17.

PMID:
22429495
23.

Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study.

Cronin-Fenton DP, Hellberg Y, Lauridsen KL, Ahern TP, Garne JP, Rosenberg C, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Acta Oncol. 2012 Feb;51(2):254-61. doi: 10.3109/0284186X.2011.633556. Epub 2011 Nov 30.

24.

Survival of women with breast cancer in central and northern Denmark, 1998-2009.

Lietzen LW, Sørensen GV, Ording AG, Garne JP, Christiansen P, Nørgaard M, Jacobsen J.

Clin Epidemiol. 2011;3 Suppl 1:35-40. doi: 10.2147/CLEP.S20627. Epub 2011 Jul 21.

25.

Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.

J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. doi: 10.1093/jnci/djr291. Epub 2011 Aug 2.

26.

Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.

Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Søiland H, Gjerde J, Garne JP, Rosenberg CL, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1937-43. doi: 10.1158/1055-9965.EPI-11-0419. Epub 2011 Jul 12.

27.

Mammography screening in Denmark.

Vejborg I, Mikkelsen E, Garne JP, Bak M, Lernevall A, Mogensen NB, Schwartz W, Lynge E.

Dan Med Bull. 2011 Jun;58(6):C4287. Review.

PMID:
21651881
28.

CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark.

Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Garne JP, Sørensen HT, Hellberg Y, Christensen M, Pedersen L, Hamilton-Dutoit S.

J Natl Cancer Inst. 2011 Mar 16;103(6):489-500. doi: 10.1093/jnci/djr010. Epub 2011 Feb 15.

29.

Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.

Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT, Pedersen L.

Acta Oncol. 2010 Apr;49(3):305-12. doi: 10.3109/02841860903575273.

30.

Overweight in relation to tumour size and axillary lymph node involvement in postmenopausal breast cancer patients-differences between women invited to vs. not invited to mammography in a randomized screening trial.

Olsson A, Garne JP, Tengrup I, Zackrisson S, Manjer J.

Cancer Epidemiol. 2009 Jul;33(1):9-15. doi: 10.1016/j.canep.2009.04.008. Epub 2009 May 6.

PMID:
19679041
31.

Body mass index and breast cancer survival in relation to the introduction of mammographic screening.

Olsson A, Garne JP, Tengrup I, Zackrisson S, Manjer J.

Eur J Surg Oncol. 2009 Dec;35(12):1261-7. doi: 10.1016/j.ejso.2009.04.012. Epub 2009 May 28.

PMID:
19481409
32.

[Overdiagnosis and overtreatment of breast cancer 2].

Garne JP, Lynge E, Kroman NT, Schwartz W.

Ugeskr Laeger. 2008 Aug 18;170(34):2596; author reply 2596. Danish. No abstract available.

PMID:
18767250
33.

Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'.

Lash TL, Ahern TP, Cronin-Fenton D, Garne JP, Hamilton-Dutoit S, Sørensen HT.

Cancer Sci. 2008 Aug;99(8):1706-7. doi: 10.1111/j.1349-7006.2008.00864.x. No abstract available.

34.

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.

Lash TL, Pedersen L, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT.

Br J Cancer. 2008 Aug 19;99(4):616-21. doi: 10.1038/sj.bjc.6604533. Epub 2008 Jul 29.

35.

[Overdiagnosis and overtreatment of breast cancer].

Garne JP, Lynge E, Vejborg I, Kroman NT, Schwartz W.

Ugeskr Laeger. 2008 Jun 2;170(23):2044; author reply 2045. Danish. No abstract available.

PMID:
18543457
36.

Parity in relation to survival following breast cancer.

Butt S, Borgquist S, Garne JP, Landberg G, Tengrup I, Olsson A, Manjer J.

Eur J Surg Oncol. 2009 Jul;35(7):702-8. doi: 10.1016/j.ejso.2008.03.017. Epub 2008 May 19.

PMID:
18490128
37.

Organized nation-wide implementation of sentinel lymph node biopsy in Denmark.

Friis E, Galatius H, Garne JP.

Acta Oncol. 2008;47(4):556-60. doi: 10.1080/02841860802010732.

PMID:
18465322
38.

Modification of tamoxifen response: what have we learned?

Lash TL, Ahern TP, Cronin-Fenton D, Garne JP, Hamilton-Dutoit S, Kvistgaard ME, Rosenberg CL, Silliman RA, Sørensen HT.

J Clin Oncol. 2008 Apr 1;26(10):1764-5; author reply 1765-6. doi: 10.1200/JCO.2007.15.5432. No abstract available.

PMID:
18375910
39.

Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group.

Madsen AH, Jensen AR, Christiansen P, Garne JP, Cold S, Ewertz M, Overgaard J.

Acta Oncol. 2008;47(2):239-47. doi: 10.1080/02841860701727436.

PMID:
18210299
40.

Trends in breast-conserving surgery in Denmark, 1982-2002.

Ahern TP, Larsson H, Garne JP, Cronin-Fenton DP, Sørensen HT, Lash TL.

Eur J Epidemiol. 2008;23(2):109-14. Epub 2007 Nov 7.

PMID:
17987392
41.

Sentinel lymph node biopsy technique and multifocal breast cancer--the Aarhus experience.

Madsen AH, Lauridsen MC, Garne JP, Iversen A, Lernevall A, Buhl L, Christiansen P.

Acta Oncol. 2007;46(5):691-6. No abstract available.

PMID:
17562447
42.

Comorbidity and survival of Danish breast cancer patients from 1995 to 2005.

Cronin-Fenton DP, Nørgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sørensen HT.

Br J Cancer. 2007 May 7;96(9):1462-8. Epub 2007 Apr 3.

43.

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.

Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP.

BMJ. 2006 Mar 25;332(7543):689-92. Epub 2006 Mar 3.

44.

[Clinical breast examination].

Christiansen PM, Garne JP.

Ugeskr Laeger. 2005 Dec 5;167(49):4642-4. Danish. No abstract available.

PMID:
16336853
45.
46.

Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?

Jensen AR, Garne JP, Storm HH, Engholm G, Möller T, Overgaard J.

Acta Oncol. 2004;43(8):719-26.

PMID:
15764216
47.

Tumour location and axillary lymph node involvement in breast cancer: a series of 3472 cases from Sweden.

Manjer J, Balldin G, Garne JP.

Eur J Surg Oncol. 2004 Aug;30(6):610-7.

PMID:
15256233
48.

Primary hyperparathyroidism: intraoperative PTH-measurements.

Rolighed L, Heickendorff L, Hessov I, Garne JP, Rodt SA, Christiansen P.

Scand J Surg. 2004;93(1):43-7.

PMID:
15116819
49.

Sentinel lymph node biopsy in breast cancer--experience with the combined use of dye and radioactive tracer at Aarhus University Hospital.

Lauridsen MC, Garne JP, Sørensen FB, Melsen F, Lernevall A, Christiansen P.

Acta Oncol. 2004;43(1):20-6.

PMID:
15068316
50.

Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations.

Jensen AR, Garne JP, Storm HH, Ewertz M, Cold S, Alvegaard T, Overgaard J.

Acta Oncol. 2003;42(7):701-9.

PMID:
14690155

Supplemental Content

Loading ...
Support Center